Chapter 19: Infections of the Urinary System
Loading audio…
ⓘ This audio and summary are simplified educational interpretations and are not a substitute for the original text.
The kidneys filter blood through nephrons, and when pathogens such as Escherichia coli from the gastrointestinal tract migrate upward through the urethra, they establish infections at various sites. The chapter categorizes infections by anatomical location: infections of the urethra (urethritis), infections of the bladder (cystitis), and the more severe kidney infections (pyelonephritis). Clinical presentation includes characteristic symptoms such as urinary urgency, burning sensation during micturition, and the presence of blood or pus in urine. Diagnosis requires a two-step approach involving collection of a properly obtained midstream sample followed by culture and sensitivity analysis, with significant bacteriuria defined as bacterial counts exceeding 100,000 colony-forming units per milliliter. Certain populations experience elevated susceptibility, including women with anatomically shorter urethras positioned near fecal sources, hospitalized patients with indwelling catheters prone to biofilm development, individuals with diabetes, and patients with anatomical abnormalities such as vesicoureteral reflux or obstructive conditions. Beyond bacterial causes, the chapter addresses viral pathogens including specific Polyomaviruses and Adenovirus species that produce hemorrhagic complications, fungal organisms particularly Candida species in immunocompromised hosts, and parasitic agents such as Schistosoma species. Treatment strategies emphasize antimicrobial therapy with agents like fluoroquinolones and sulfonamide combinations, requiring complete adherence to prescribed courses to prevent therapeutic failure and resistance development. The chapter concludes by discussing preventive approaches including behavioral modifications such as adequate hydration and appropriate voiding practices, proper catheter management protocols, and emerging immunological interventions designed to block bacterial adhesion mechanisms to urinary epithelial tissues.